DK201889A - Cyclodextrinkomplekser af en 5-aminohexahydropyrimidinforbindelse, deres fremstilling og anvendelse - Google Patents

Cyclodextrinkomplekser af en 5-aminohexahydropyrimidinforbindelse, deres fremstilling og anvendelse Download PDF

Info

Publication number
DK201889A
DK201889A DK201889A DK201889A DK201889A DK 201889 A DK201889 A DK 201889A DK 201889 A DK201889 A DK 201889A DK 201889 A DK201889 A DK 201889A DK 201889 A DK201889 A DK 201889A
Authority
DK
Denmark
Prior art keywords
aminohexahydropyrimide
compound
preparation
cyclodextrin complexes
cyclodextrin
Prior art date
Application number
DK201889A
Other languages
Danish (da)
English (en)
Other versions
DK201889D0 (da
Inventor
Andrew Robert Gallopo
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DK201889D0 publication Critical patent/DK201889D0/da
Publication of DK201889A publication Critical patent/DK201889A/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/738Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DK201889A 1988-04-27 1989-04-26 Cyclodextrinkomplekser af en 5-aminohexahydropyrimidinforbindelse, deres fremstilling og anvendelse DK201889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18653688A 1988-04-27 1988-04-27

Publications (2)

Publication Number Publication Date
DK201889D0 DK201889D0 (da) 1989-04-26
DK201889A true DK201889A (da) 1989-10-28

Family

ID=22685337

Family Applications (1)

Application Number Title Priority Date Filing Date
DK201889A DK201889A (da) 1988-04-27 1989-04-26 Cyclodextrinkomplekser af en 5-aminohexahydropyrimidinforbindelse, deres fremstilling og anvendelse

Country Status (11)

Country Link
EP (1) EP0340171A3 (ja)
JP (1) JPH0242066A (ja)
KR (1) KR890015723A (ja)
AU (1) AU608707B2 (ja)
DK (1) DK201889A (ja)
FI (1) FI891931A (ja)
MX (1) MX172302B (ja)
NO (1) NO891706L (ja)
NZ (1) NZ228848A (ja)
PT (1) PT90371A (ja)
ZA (1) ZA892684B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2013485C (en) * 1990-03-06 1997-04-22 John Michael Gardlik Solid consumer product compositions containing small particle cyclodextrin complexes
KR100304064B1 (ko) * 1993-08-12 2001-11-22 다카하시 미치나오 구강용조성물
PE20020300A1 (es) 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
CN114874359B (zh) * 2022-04-29 2023-03-28 同济大学 一种嘧啶-环糊精聚合物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB771768A (en) * 1953-11-19 1957-04-03 Warner Lambert Pharmaceutical Improved dental therapeutic compositions
GB2001526A (en) * 1977-07-26 1979-02-07 Warner & Co Ltd W Dentifrice containing hexetidine and fluorides
DE2829037A1 (de) * 1978-07-01 1980-01-10 Fresenius Chem Pharm Ind Wasserloesliche, keimtoetende mittel enthaltende mund- und rachenpflegemittel
JPS55122709A (en) * 1979-03-13 1980-09-20 Asama Kasei Kk Stench remover from mouth
ZA884592B (en) * 1987-08-31 1989-03-29 Warner Lambert Co Cyclodextrin complexes of bis-biguanido hexane compounds
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.

Also Published As

Publication number Publication date
MX172302B (es) 1993-12-13
KR890015723A (ko) 1989-11-25
AU608707B2 (en) 1991-04-11
FI891931A0 (fi) 1989-04-24
EP0340171A3 (en) 1990-03-21
FI891931A (fi) 1989-10-28
NZ228848A (en) 1990-10-26
NO891706D0 (no) 1989-04-25
AU3329089A (en) 1989-11-02
DK201889D0 (da) 1989-04-26
NO891706L (no) 1989-10-30
ZA892684B (en) 1989-12-27
PT90371A (pt) 1989-11-10
JPH0242066A (ja) 1990-02-13
EP0340171A2 (en) 1989-11-02

Similar Documents

Publication Publication Date Title
DK8189D0 (da) Antigen-antistof-konjugater, deres fremstilling og anvendelse
DK609489A (da) Imidazolderivater, deres fremstilling og anvendelse
DK584789D0 (da) Fungicider
DK303890D0 (da) Spilleautomat
DK540389D0 (da) Immunstimulerende praeparat
DK374289D0 (da) Indazol-3-carboxylsyrederivater, deres fremstilling og anvendelse
KR900700462A (ko) 피리다지논 유도체
DK388588A (da) N-substituerede-5,6-dimethoxy-1,2-benzisoxazol-3-propanaminer og hermed beslaegtede forbindelser, deres fremstilling og anvendelse
NO895030D0 (no) 2-imino-benzotiazolinderivater og deres fremstilling.
DK371088D0 (da) Azacykliske forbindelser, deres fremstilling og anvendelse
DK201889A (da) Cyclodextrinkomplekser af en 5-aminohexahydropyrimidinforbindelse, deres fremstilling og anvendelse
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK469389A (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
NO179073C (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
KR900700455A (ko) 치료제
DK606288D0 (da) Praeparat
DK233689A (da) Fremstilling af 2,3-dideoxynukleosider
DK639889D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK625988D0 (da) Imidazoquinoxalinforbindelser, deres fremstilling og anvendelse
DK142288D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK258289D0 (da) Imidazoquinoxalin forbindelser, deres fremstilling og anvendelse
DK639789D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK297188D0 (da) Imidazoquinoxalinforbindelser, deres fremstilling og anvendelse
DK343689D0 (da) Herbicidt praeparat
DK494489D0 (da) Cis-platin-komplekser, deres fremstilling og anvendelse

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment